Article info

Download PDFPDF

Original research
Upadacitinib in active ankylosing spondylitis: results of the 2-year, double-blind, placebo-controlled SELECT-AXIS 1 study and open-label extension

Authors

  1. Correspondence to Professor Désirée van der Heijde; mail{at}dvanderheijde.nl
View Full Text

Citation

van der Heijde D, Deodhar A, Maksymowych WP, et al
Upadacitinib in active ankylosing spondylitis: results of the 2-year, double-blind, placebo-controlled SELECT-AXIS 1 study and open-label extension

Publication history

  • Received February 8, 2022
  • Accepted June 23, 2022
  • First published July 27, 2022.
Online issue publication 
July 27, 2022
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.